Tweedy, Browne Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Tweedy, Browne Co's BMY Position: Q2 2026 in Review
Tweedy, Browne Co increased its Bristol-Myers Squibb (BMY) stake by 44% in Q2 2026, buying an estimated $655K and bringing the position to 37,570 shares worth $2.16M. The position accounts for 0.16% of the portfolio, ranked #50.
Tweedy, Browne Co first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Tweedy, Browne Co held 37,570 shares of Bristol-Myers Squibb worth $2.16M as of Q2 2026.
- Tweedy, Browne Co bought 11,412 Bristol-Myers Squibb shares in Q2 2026, an estimated $655K.
- Bristol-Myers Squibb made up 0.16% of Tweedy, Browne Co's portfolio in Q2 2026, its #50 holding.
- Tweedy, Browne Co first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Tweedy, Browne Co's 13F filing for Q2 2026, filed 7 Aug 2026.